Helsinki - Delayed Quote EUR

Bioretec Oy (BRETEC.HE)

Compare
2.4100 -0.3600 (-13.00%)
At close: October 4 at 6:29 PM GMT+3
Loading Chart for BRETEC.HE
DELL
  • Previous Close 2.7700
  • Open 2.7700
  • Bid 2.4000 x --
  • Ask 2.4100 x --
  • Day's Range 2.3300 - 2.7800
  • 52 Week Range 2.0200 - 3.0100
  • Volume 115,266
  • Avg. Volume 20,949
  • Market Cap (intraday) 49.012M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1700
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.00

Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery. It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants. The company was formerly known as BCI Bioabsorbable Concepts Oy. Bioretec Ltd. was incorporated in 1998 and is headquartered in Tampere, Finland.

bioretec.com

--

Full Time Employees

--

Fiscal Year Ends

Recent News: BRETEC.HE

View More

Performance Overview: BRETEC.HE

Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BRETEC.HE
0.42%
MSCI WORLD
16.70%

1-Year Return

BRETEC.HE
5.12%
MSCI WORLD
32.10%

3-Year Return

BRETEC.HE
16.90%
MSCI WORLD
0.00%

5-Year Return

BRETEC.HE
31.04%
MSCI WORLD
21.95%

Compare To: BRETEC.HE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BRETEC.HE

View More

Valuation Measures

Annual
As of 10/4/2024
  • Market Cap

    49.01M

  • Enterprise Value

    46.91M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    13.46

  • Price/Book (mrq)

    7.58

  • Enterprise Value/Revenue

    11.51

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -0.1700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BRETEC.HE

View More

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

3.00
3.00 Average
2.4100 Current
3.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: BRETEC.HE

People Also Watch